Glucose Response, Excursions And Treatment (GREAT) Study

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Type 2 Diabetes
Interventions
DRUG

DPPIV inhibitor -

Mixed Meal Tolerance Test with or without a DPPIV inhibitor

DEVICE

Continuous glucose monitoring system.

participant's will self-monitor blood glucose over a 4-6 day period via a CGM monitor inserted just under the skin.

Trial Locations (1)

EX1 2TD

NIHR Exeter Clinical Research Facility, Exeter

All Listed Sponsors
collaborator

NIHR Exeter Clinical Research Facility

NETWORK

lead

Royal Devon and Exeter NHS Foundation Trust

OTHER